BSX

#218
Boston Scientific Corporation Common Stock
48.3 3 USD
-2.21%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
48.13
48.63
년간 변동
48.13
109.49
일일 변동
-2.21%
월간 변동
-15.33%
6달 변화
-52.52%
년간 변동율
-53.76%
이전 종가
49.4 2
Open
48.3 0
저가
48.1 3
High
48.6 3
양
11.2 K
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 71.84 B
  • Employee 59 K
  • Founded 1979
  • CEO Michael F. Mahoney
  • Website www.bostonscientific.com
  • Headquarter Delaware, United States
  • FIGI BBG000C0LW92
  • Industry 의료 기기
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
26.26
주가매출액비율
4.55

Boston Scientific Corporation Common Stock

Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware.

뉴스